Moderna (MRNA) Historical Monthly & Quarterly Returns
Dividend-adjusted returns by month and quarter. Compare performance across years.
Moderna
MRNA
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +49.4% | +21.6% | 5.2% | 10.0% | — | — | — | — | — | — | — | — |
| 2025 | 5.2% | 21.5% | 8.4% | +0.7% | 6.9% | +3.9% | +7.1% | 18.5% | +7.2% | +5.1% | 4.3% | +13.5% |
| 2024 | +1.6% | 8.7% | +15.5% | +3.5% | +29.2% | 16.7% | +0.4% | 35.1% | 13.7% | 18.7% | 20.8% | 3.4% |
| 2023 | 2.0% | 21.2% | +10.6% | 13.5% | 3.9% | 4.9% | 3.2% | 3.9% | 8.6% | 26.5% | +2.3% | +28.0% |
| 2022 | 33.3% | 9.3% | +12.1% | 22.0% | +8.1% | 1.7% | +14.9% | 19.4% | 10.6% | +27.1% | +17.0% | +2.1% |
| 2021 | +65.8% | 10.6% | 15.4% | +36.6% | +3.5% | +27.0% | +50.5% | +6.5% | +2.2% | 10.3% | +2.1% | 27.9% |
| 2020 | +4.9% | +26.4% | +15.5% | +53.6% | +33.7% | +4.4% | +15.4% | 12.4% | +9.0% | 4.6% | +126.4% | 31.6% |
| 2019 | +8.7% | +36.1% | 10.0% | +27.9% | 20.2% | 29.5% | 10.5% | +20.1% | +1.2% | +5.2% | +21.6% | 3.9% |
| 2018 | — | — | — | — | — | — | — | — | — | — | — | 17.9% |
| Avg | +11.2% | +1.6% | +1.9% | +9.6% | +6.2% | 2.5% | +10.7% | 9.0% | 1.9% | 3.2% | +20.6% | 5.1% |
| Median | +3.2% | 9.0% | +2.7% | +2.1% | +3.5% | 1.7% | +7.1% | 12.4% | +1.2% | 4.6% | +2.3% | 3.7% |
| Win % | 63% | 38% | 50% | 63% | 57% | 43% | 71% | 29% | 57% | 43% | 71% | 38% |
2026
Jan+49.4%
Feb+21.6%
Mar5.2%
Apr10.0%
May—
Jun—
Jul—
Aug—
Sep—
Oct—
Nov—
Dec—
2025
Jan5.2%
Feb21.5%
Mar8.4%
Apr+0.7%
May6.9%
Jun+3.9%
Jul+7.1%
Aug18.5%
Sep+7.2%
Oct+5.1%
Nov4.3%
Dec+13.5%
2024
Jan+1.6%
Feb8.7%
Mar+15.5%
Apr+3.5%
May+29.2%
Jun16.7%
Jul+0.4%
Aug35.1%
Sep13.7%
Oct18.7%
Nov20.8%
Dec3.4%
2023
Jan2.0%
Feb21.2%
Mar+10.6%
Apr13.5%
May3.9%
Jun4.9%
Jul3.2%
Aug3.9%
Sep8.6%
Oct26.5%
Nov+2.3%
Dec+28.0%
2022
Jan33.3%
Feb9.3%
Mar+12.1%
Apr22.0%
May+8.1%
Jun1.7%
Jul+14.9%
Aug19.4%
Sep10.6%
Oct+27.1%
Nov+17.0%
Dec+2.1%
2021
Jan+65.8%
Feb10.6%
Mar15.4%
Apr+36.6%
May+3.5%
Jun+27.0%
Jul+50.5%
Aug+6.5%
Sep+2.2%
Oct10.3%
Nov+2.1%
Dec27.9%
2020
Jan+4.9%
Feb+26.4%
Mar+15.5%
Apr+53.6%
May+33.7%
Jun+4.4%
Jul+15.4%
Aug12.4%
Sep+9.0%
Oct4.6%
Nov+126.4%
Dec31.6%
2019
Jan+8.7%
Feb+36.1%
Mar10.0%
Apr+27.9%
May20.2%
Jun29.5%
Jul10.5%
Aug+20.1%
Sep+1.2%
Oct+5.2%
Nov+21.6%
Dec3.9%
2018
Jan—
Feb—
Mar—
Apr—
May—
Jun—
Jul—
Aug—
Sep—
Oct—
Nov—
Dec17.9%
Avg
Jan+11.2%
Feb+1.6%
Mar+1.9%
Apr+9.6%
May+6.2%
Jun2.5%
Jul+10.7%
Aug9.0%
Sep1.9%
Oct3.2%
Nov+20.6%
Dec5.1%
Median
Jan+3.2%
Feb9.0%
Mar+2.7%
Apr+2.1%
May+3.5%
Jun1.7%
Jul+7.1%
Aug12.4%
Sep+1.2%
Oct4.6%
Nov+2.3%
Dec3.7%
Win %
Jan63%
Feb38%
Mar50%
Apr63%
May57%
Jun43%
Jul71%
Aug29%
Sep57%
Oct43%
Nov71%
Dec38%
Frequently asked questions
What is the best performing month for Moderna (MRNA) stock?
- Historically, November is the best performing month for Moderna (MRNA) stock with an average return of +20.60%.
What is the worst performing month for Moderna (MRNA) stock?
- Historically, August is the worst performing month for Moderna (MRNA) stock with an average return of 8.96%.
What is the best performing quarter for Moderna (MRNA) stock?
- Historically, Q2 is the best performing quarter for Moderna (MRNA) stock with an average return of +15.82%.
What is the worst performing quarter for Moderna (MRNA) stock?
- Historically, Q3 is the worst performing quarter for Moderna (MRNA) stock with an average return of +0.06%.
What is the best performing year for Moderna (MRNA) stock?
- Historically, 2020 is the best performing year for Moderna (MRNA) stock with a return of +434.10%.
What is the worst performing year for Moderna (MRNA) stock?
- Historically, 2024 is the worst performing year for Moderna (MRNA) stock with a return of 58.19%.
Which month has the highest win rate for Moderna (MRNA) stock?
- Historically, July has the highest win rate for Moderna (MRNA) stock — positive in 71% of years.
Which month has the lowest win rate for Moderna (MRNA) stock?
- Historically, August has the lowest win rate for Moderna (MRNA) stock — positive in 29% of years.
Which quarter has the highest win rate for Moderna (MRNA) stock?
- Historically, Q1 has the highest win rate for Moderna (MRNA) stock — positive in 63% of years.
Which quarter has the lowest win rate for Moderna (MRNA) stock?
- Historically, Q2 has the lowest win rate for Moderna (MRNA) stock — positive in 38% of years.
Data & methodology
How are returns calculated?
- We compare the closing price at the end of each period (month or quarter) with the closing price at the end of the previous period. The return is the percentage change. All prices are adjusted for dividends and stock splits. Based on historical prices from our data provider.
What is average vs median?
- Average is the arithmetic mean of returns for each period across years. Median is the middle value. Both exclude empty cells. Use median to reduce impact of outliers.
What does the heatmap show?
- Green cells indicate positive returns, red cells indicate negative returns. The darker the color, the stronger the move. Average and Median rows summarize each column across years.
What is Win %?
- Percentage of years when the period had a positive return. For example, 80% for January means January was positive in 80% of the years in the selected range.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
Explore
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
Explore
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
Explore
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
Explore
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
Explore
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
Explore
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Explore
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
Explore
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
Explore
MRNA Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.
Explore